carbamates has been researched along with Bright Disease in 3 studies
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maanaoui, M | 1 |
| Saint-Jacques, C | 1 |
| Gnemmi, V | 1 |
| Frimat, M | 1 |
| Lionet, A | 1 |
| Hazzan, M | 1 |
| Noël, C | 1 |
| Provot, F | 1 |
| Chia, XX | 1 |
| Cherepanoff, S | 1 |
| Danta, M | 1 |
| Furlong, T | 1 |
| Lagrue, G | 1 |
| Hirbec, G | 1 |
| Moisy, M | 1 |
| Sternberg, M | 1 |
| Blanc, C | 1 |
3 other studies available for carbamates and Bright Disease
| Article | Year |
|---|---|
Glomerulonephritis and granulomatous vasculitis in kidney as a complication of the use of BRAF and MEK inhibitors in the treatment of metastatic melanoma: A case report.
Topics: Antineoplastic Agents; Benzimidazoles; Carbamates; Female; Glomerulonephritis; Humans; Kidney; Lung | 2017 |
Successful treatment of HCV-related glomerulonephritis with sofosbuvir and daclatasvir.
Topics: Antiviral Agents; Carbamates; Glomerulonephritis; Hepacivirus; Hepatitis C, Chronic; Host-Pathogen I | 2018 |
[Action of pyridinol carbamate on hetero-immune Masugi nephritis in the rat (author's transl)].
Topics: Animals; Capillary Permeability; Carbamates; Disease Models, Animal; Glomerulonephritis; Immune Sera | 1976 |